Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:ICOTF

iCo Therapeutics (ICOTF) Stock Price, News & Analysis

iCo Therapeutics logo

About iCo Therapeutics Stock (OTCMKTS:ICOTF)

Advanced Chart

Key Stats

Today's Range
$0.51
$0.56
50-Day Range
$0.30
$0.42
52-Week Range
$0.80
$1.82
Volume
90,488 shs
Average Volume
4,760 shs
Market Capitalization
$4.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.

Receive ICOTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ICOTF Stock News Headlines

MSCLF Satellos Bioscience Inc.
ICO Group Ltd.
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
Satellos Bioscience Inc (MSCL)
See More Headlines

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ICOTF
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.11 million
Pretax Margin
-4,148.78%

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-7.29

Miscellaneous

Free Float
N/A
Market Cap
$4.62 million
Optionable
Not Optionable
Beta
2.03
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:ICOTF) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners